BIOMAKERS
BIOMAKERS provides genomic and molecular diagnostic testing to inform treatment and clinical trial matching for cancer and rare disease patients. The company combines next-generation sequencing, molecular pathology, bioinformatics, and AI-enhanced analysis to generate genomic datasets, biomarker reports, and patient stratification tools. It operates as a B2B services provider with sequencing labs in Mexico, Brazil, and Argentina, logistics for sample collection across Latin America, and partnerships with pharmaceutical companies for drug development and biomarker validation. BIOMAKERS targets healthcare providers, researchers, and biopharma clients to support precision medicine and oncology drug development in the LATAM market.
BIOMAKERS
BIOMAKERS provides genomic and molecular diagnostic testing to inform treatment and clinical trial matching for cancer and rare disease patients. The company combines next-generation sequencing, molecular pathology, bioinformatics, and AI-enhanced analysis to generate genomic datasets, biomarker reports, and patient stratification tools. It operates as a B2B services provider with sequencing labs in Mexico, Brazil, and Argentina, logistics for sample collection across Latin America, and partnerships with pharmaceutical companies for drug development and biomarker validation. BIOMAKERS targets healthcare providers, researchers, and biopharma clients to support precision medicine and oncology drug development in the LATAM market.